Blistering disorders and their differential diagnosis and management
|
|
- Louisa Short
- 5 years ago
- Views:
Transcription
1 and their differential diagnosis and management STEVE KOSSARD, MB BS, PhD, FACD The type and pattern of cutaneous blisters may provide an essential clue to the diagnosis of specific dermatological disorders. Physical and chemical injury, insect bites, contact dermatitis, medications and infections are the most frequent causes of selflimited blisters in general practice. Individuals with persistent and puzzling forms of blistering disease may have a variety of autoimmune blistering skin disorders including bullous pemphigoid and pemphigus or have epidermolysis bullosa or porphyria. Drug-related blistering may mimic these dermatoses and should always be considered a potential cause. The development of blisters is a feature which is shared by a large number of skin disorders. The ultimate diagnosis often is readily apparent from the clinical history and presentation, but occasionally may require a range of investigations including skin biopsy, immunofluorescence or ultrastructural studies. Blisters are traditionally classified as vesicles if they measure less than 0,5 cm in diameter and bullae if they are larger. Superficially located blisters which are intraepidermal or subcorneal tend Dr Kossard is Consultant, Skin and Cancer Foundation, Darlinghurst; and Visiting Dermatologist, St Vincent's Hospital, Sydney, NSW, Australia. He wrote this article specially for MODERN MEDICINE. to be flaccid and transitory while subepidermal blisters are often tense and are more readily identified. A practical approach to the diagnosis of cutaneous vesiculobullous disorders is to consider common causes (Table 1) which may result in blisters prior to considering the bullous disorders as a special group. Common causes of skin blisters Chemical or physical injury This usually provides no difficulties in diagnosis and usually the blisters are painful, asymmetrical and correspond to the site of contact. Occasionally a chemical contactant may not be readily identified or suspected in the workplace. Contact dermatitis This is characterized by markedly pruritic vesiculobullous reactions which may have a Linear or streaked configuration (Figure 1) on the exposed sites due to plants such as the rhus tree (Figure 2). There is often a lag of 24 to 48 hours after contact with the allergen prior to the development of lesions, reflecting a delayed hypersensitivity reaction. Most cases can be managed with topical corticosteroids, but severe and extensive involvement may require a course of oral prednisone (Meticorten, et al) commencing at a dose of 40 mg in the morning, reducing by 10 mg weekly decrements for four weeks to avoid rebound of the rash. Insect bite reactions These often are scattered and appear as grouped excoriated pruritic papules on exposed TABLE 1 Common causes for skin blisters Physical or chemical injury Contact dermatitis Insect bites Herpes simplex Impetigo Drugs MODERN MEDICINE OF SOUTH AFRICA 9
2 continued Contact dermatitis may appear af t e r a [ a g 0f hours after contact with the allergen: this is a delayed hypersensitivity reaction. Figure 3. Grouped blisters on lower limbs due to insect Figure 4. Clusters of vesicles bites. cipated by sun exposure. sites. They are more often bullous in young children, migrants or the elderly (Figure 3). Insect bites may benefit symptomatically from the use of topical antihistamine creams; insect repellants should be utilized to diminish subsequent episodes. Herpes simplex Herpes simplex is readily recognized as grouped vesicles recurring at a localized site with MODERN MEDICINE OF SOUTH AFRICA 99
3 Impetigo blisters are superficial and continued I ten(i f0 transitory, resulting in multiple, crusted, highly contagious lesions. a self-limited course (Figure 4). Herpes may pose difficulties in diagnosis when the lesions are extensive in a primary episode or in disseminated infections and also when the lesions are at an unusual site. A Tzanck smear of the blister floor on a glass slide reveals viral giant cells allowing for rapid diagnosis. Acyclovir (Zovirax) has proved to be a valuable agent in the treatment of frequent recurrent episodes of herpes simplex and in disseminated infections, particularly in immunocompromised patients. Impetigo Impetigo blisters are superficially located and tend to be transitory resulting in multiple, crusted lesions which are highly contagious and usually are associated with staphylococcal infection. Blistering also may occur overlying a cellulitis due to Staphylococcus (Figure 5). Topical mupirocin ointment (Bactroban) is a useful addition for the treatment of localized impetigo. Drugs Drugs may cause blisters through a variety of mechanisms and may mimic a range of dermatoses which will be detailed prior to summarizing the varied drug reactions which may be bullous. Allergic and autoimmune bullous disorders (Table 2) Erythema multiforme Erythema multiforme represents an allergic reaction which is characterized by symmetrical papular eruption localized particularly to the extensor surfaces of the limbs. The lesions often have a target-like appearance and may be bull- Figure 5. Cellulitis with blisters due to staphylococcal Figure 7. Burn-like blisters infections. necrolysis. Figure 6. Target lesions associated with erythema multi- Figure 8. Tense blisters on forme. with bullous pemphigoid. 1 MODERN MEDICINE OF SOUTH AFRICA / OCTOBER 1990
4 continued. Dermatitis herpetiformis is intensely I p r u rm c ; although few patients have bowel symptoms, gluten-sensitive enteropathy is almost universal. Figure S. Linear deposition of immunoglobulin Figure 11. along Excoriated papulovesicular lesions i basement membrane zone seen on immunofluorescence metrical distribution on the trunk and elbows typica in bullous pemphigoid. matitis herpetiformis. Figure 10. Flaccid blisters on chest wall Figure of a patient 12. Blisters with and scars on the dorsum of ha pemphigus vulgaris. patient with porphyria. ous (Figure 6). Generalized erythema multiforme with severe involvement of the mucous membranes has been designated as the Stevens- Johnson syndrome. Extensive involvement of the skin may result in burn-like blisters termed "toxic epidermal necrolysis" (TEN) (Figure 7). Herpes simplex and drugs are the most frequent triggering MODERN MEDICINE OF SOUTH AFRICA 10
5 continued Pemphigus vulgaris used to be a fatal disorder, but the use of high dose oral steroids controls it: immunosuppressive agents have changed the outlook. factors for this reaction pattern. Acyclovir has been used prophylactically with success to prevent recurrent erythema multiforme triggered by herpes simplex. The use of oral corticosteroids has not been shown to alter the ultimate course of severe erythema multiforme. Bullous pemphigoid This may occur at all ages but particularly affects the elderly. It is characterized by urticarial plaques followed by tense blisters (Figure 8). Blisters are often generalized and may be accentuated in the flexural areas. A similar disorder termed "herpes gestationis" may occur during pregnancy. A variant of bullous pemphigoid involving the mucous membranes and resulting in scarring and occasionally blindness is termed "cicatricial pemphigoid". This group of autoimmune disorders all have circulating antibodies which are directed against the basement membrane zone (Figure 9) resulting in subepidermal blisters. Any elderly individual who suddenly develops widespread pruritic blisters which are tense should be biopsied as bullous pemphigoid can readily be diagnosed. Oral prednisone, commencing usually at a dose of 60 mg, remains the mainstay of management of bullous pemphigoid and usually needs to be continued for several years at a low dose (5-10 mg prednisone) to prevent relapse. Pemphigus vulgaris This is characterized by flaccid blisters often arising on normal skin (Figure 10). The peak incidence occurs in patients aged between 40 and 60 years. In most patients the initial lesions are localized to the oral mucous membranes. A superficial form which is localized particularly to the upper trunk and face may resemble impetigo and is termed "pemphigus foliaceus". Pemphigus is associated with circulating antibodies directed against the intercellular substance between the keratinocytes of the epidermis resulting in loss of intercellular adhesion and a process of acantholysis. Any chronic blistering or erosive process affecting the mucous membranes should be biopsied to rule out potentially serious bullous dermatoses such as pemphigus or cicatricial pemphigoid. Pemphigus vulgaris was formerly a fatal disorder but the use of high dose, oral steroids often exceeding 100 mg prednisone to bring the clinical activity under control and subsequent addition of immunosuppressive agents, such as azathioprine (Imuran, et al) has radically changed the outlook. Dermatitis herpetiformis This is an intensely pruritic disorder characterized by excoriated papulovesicular lesions localized particularly over the extensor surface of the elbows and knees and extending over the back (Figure 11), buttocks, face and scalp. The lesions may become bullous. The disorder occurs at all ages, but particularly in middle life. Skin biopsy 1 MODERN MEDICINE OF SOUTH AFRICA/OCTOBER 1990 shows neutrophilic microabscesses in the dermal papillae associated with granular IgA deposition demonstrable by immunofluorescence. Although the majority of patients do not have bowel symptoms, glutensensitive enteropathy is found almost universally. The control of this with a gluten-free diet has had a positive effect on the cutaneous disease. Dapsone, at a dosage of mg, remains the major form of treatment and often the rapidity of the clinical response is dramatic in dermatitis herpetiformis. Special bullous disorders Epidermolysis bullosa This is represented by a range of blistering disorders due to structural abnormalities in the skin affecting its capacity to resist injury. This group is characterized by mechanical fragility of the skin and ranges from fatal forms presenting in the neonatal period to mild forms confined to the palms and soles in adults. Ultrastructural studies have helped to separate subtypes and recently prenatal sampling has allowed early diagnosis to be established. The level of the blister in epidermolysis bullosa may occur intraepidermally (epidermolytic), through the basement membrane (junctional) or under the basement membrane (dermolytic). The dystrophic recessive form, which is dermolytic, leads to extensive scarring and may eventually be complicated by multiple skin cancers. Careful skin care and
6 1. SCHEDULING STATUS: S3 2. PROPRIETARY NAME (AND DOSAGE FORM): Lopid Capsules 3. COMPOSITION: Capsules containing 300mg gemfibrozil Special precautions: Diabetes Mellitus: As gemfibrozil may elevate the fasting blood sugarsduring treatment periodic blood sugar determinationsareadvisable in diabetics receiving LOPID toassureadequate control. Cholelithiasis: Because LOPID may increase cholesterol excretion into the bile leading to cholelithiasis, gallbladder studiesare indicated if cholelithiasis issuspected. LOPID therapy should be discontinued if gallstones are found. 4. PHARMACOLOGICAL CLASSIFICATION: Category A: 7.5 Serum-cholesterol reducers 5. PHARMACOLOGICAL ACTION: LOPID is a lipid-regulating agent which produces an increase in the cholesterol content of the high density lipoprotein (HDL) fraction and lowers elevated total serum cholesterol and triglycerideconcentrationsdue todecreases in thevery lowdensity lipoprotein (VLDL) and low density lipoprotein (LDL) fractions. The mechanism by which these actions occur has not been firmly established. In animalstudies LOPID has been shown to reduce the incorporation of long-chain fatty acids into rat liver triglycerides and to inhibit adipose tissue lipolysis. In humans LOPID inhibits peripheral lipolysis and decreasesthe hepatic uptake of plasma free fatty acids leading to reduced hepatic triglyceride production. It also inhibits the production and increases the turnover rate of the ^-apoprotein moiety of VLDL, the resulting decrease in VLDL providing the basis for the drug's ability to reduce total lipid levels. Lopid increases plasma HDL levels by stimulating the synthesis of the major apolipoproteins of HDL. 6. INDICATIONS: Lopid is indicated as adjunctive therapy to diet and weight loss in the treatment of the following hyperlipidaemias: 1. Fredrickson Type lla 2. Fredrickson Type lib 3. Fredrickson Type IV NOTE: LOPID should be prescribed only for patients with a potentially responsive lipid or lipoprotein abnormality where appropriate dietary therapy alone is insufficient to correct the condition. Excess body weight and excessive alcohol intake may be important factors in hypertriglyceridaemia and should be addressed prior to any drug therapy. Appropriate physical exercise may be a valuable ancillary measure. Contributory underlying pathology should be adequately treated e.g. hypothyroidism and diabetes mellitus. 7. CONTRA-INDICATIONS: (1) Hepatic and/or severe renal dysfunction, including primary biliary cirrhosis (2) Gall-stones (3) Hypersensitivity to gemfibrozil. Safe use in pregnancy has not yet been established. It is not known whether or not gemfibrozil is secreted in human milk. Gemfibrozil should be avoided during pregnancy and lactation. Safety and efficacy in children have not been established. 8. DOSAGE AND DIRECTIONS FOR USE: 1200mg in divided dosestwicedaily. 900mg in divided doses twice daily will prove sufficient in some patients and should be tried in cases of intolerance at normal dosage. When maximal triglyceride reduction is desired up to 1500mg daily in divided doses may be needed. 9. SIDE-EFFECTS AND SPECIAL PRECAUTIONS: Side-effects. The most frequently occurring side-effects are gastro-intestinal and include abdominal and epigastric pain, diarrhoea, dyspepsia and flatulence, nausea and vomiting. Other important side-effects include headache, fatigue, rash, dermatitis, pruritus, urticaria, vertigo, impotence, myositis manifesting as painful extremities and myalgia accompanied by an increase in creatine phosphokinase. Other possibly related side-effects to which the physician should be alerted include dry mouth, constipation, anorexia, blurred vision, paraesthesia and tinnitus, insomnia, malaiseand syncope, arthralgia, swollen jointsand musclecramps, back pain, hypokalemia, leucopenia and anaemia. Drug Interactions: As prothrombin time may be increased if coumarin-type anticoagulants are administered inconjunction with LOPID, caution should be exercised. The dosage of the anticoagulant should be reduced to maintain the prothrombin time at the desired level to prevent bleeding complications. Frequent prothrombin determinations are advisable until it has been definitely determined that the prothrombin level has stabilized. General Because long-term administration of LOPID may be needed, all baseline values including lipid profile, blood count and liver function tests, should be reliably measured beforetreatmentand periodicdeterminationsof serum lipidsshould be obtained. The drug should be withdrawn after 3 months if the response is inadequate. A paradoxical elevation of serum lipids has occasionally been observed, usually in patients with alcoholic hepatic disease. Mild haemoglobin, haematocrit and white blood celldecreases have been observed in occasional patients following initiation of LOPID therapy. However, these levels stabilize during long-term administration. Therefore, periodic blood counts are recommended during the first 12 months of LOPID administration. Abnormal liver function tests have been observed occasionally during LOPID administration, including elevationsofsgot.sgpt, LDH, and alkaline phosphatase. These are usually reversible when LOPID is discontinued. Therefore periodic liver function studies are recommended and LOPID therapy should be terminated if abnormalities persist. 10. KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT: Symptomatic and/or supportive treatment. 11. IDENTIFICATION: Capsule with white opaque body and maroon opaque cap, imprinted LOPID and LOPID 300 in grey ink. 12. PRESENTATION: 300mg capsules in packs of STORAGE INSTRUCTIONS: Store in a cool (15 C to 25 C), dry place out of the reach of children. 14. REGISTRATION NUMBER: S/7.5/295 Lopid reduces the risk by raising HDL and lowering LDL cholesterol 15. NAME AND BUSINESS ADDRESS OF THE APPLICANT: PARKE-DAVIS, Division of WARNER-LAMBERTS.A. (Pty) Ltd. 241 Main Road, RETREAT DATE OF PUBLICATION OF THIS PACKAGE INSERT: 7 February 1990
7 continued. Regular venesection to lower the serum iron levels has been the most important treatment of porphyria cutanea tarda. TABLE 2 Differential diagnosis of autoimmune bullous disorders Lesion Major sites Level of blister Immunofluorescence Bullous pemphigoid Tense blister Cicatricial pemphigoid Erosions, scars Herpes gestationis* Grouped blisters Pemphigus vulgaris Flaccid blister, erosions Pemphigus foliaceus Erosions, crusts Dermatitis herpetiformis Excoriated papulovesicles "During pregnancy and postpartum period Generalized skin Mucous membranes Trunk, limbs Mucous membrane Upper trunk, face Knees, elbows, buttocks (lamina lucida) (lamina lucida) (lamina lucida) Intraepidermal Subcorneal (under basal lamina) Linear; basement membrane zone Linear; basement membrane zone Linear; basement membrane zone Intercellular Intercellular Dermal papillae protection remains the mainstay of management in epidermolysis bullosa although occasionally phenytoin sodium (Epanutin) may benefit individual cases. Porphyria Porphyria presents characteristically in middle-aged individuals who have increased skin fragility and blisters over the dorsal aspect of their hands associated with scarring (Figure 12). Skin hyperpigmentation, hypertrichosis and facial suffusion may be additional signs. Oestrogens and alcohol may precipitate the disorder. Measurement of urinary porphyrins will establish the diagnosis. Regular venesection to lower the serum iron levels has been the most effective treat- TABLE 3 Bullous drug reactions Erythema muttiforme Fixed drug eaction Toxic epidermal necrolysis - Phototoxic Pseudoporphyria Pemphigus ment of porphyria cutanea tarda. Bullous drug reactions (Table 3) Erythema multiforme This may be precipitated by drugs such as sulphonamides, penicillin, phenytoin sodium and phenylbutazone. A fixed drug reaction This is characterized by localized erythematous plaques which may blister and typically heal with hyperpigmentation. The lesions may be on mucous surfaces, and recur at the same sites on readministration of the specific drug. Tetracyclines, sulphonamides and phenolphthalein are among the most common precipitants. Toxic epidermal necrolysis This is characterized by the sudden development of tender erythematous skin which is shed as loose sheets simulating a burn. It rapidly becomes generalized and is associated with mucous membrane involvement. Approximately 50% of patients follow a fatal course despite intensive treatment. Allopurinol, phenytoin sodium and sulphonamides are among the most common causes. Phototoxic drug reactions These mimic sunburn and may culminate with painful blisters on exposed sites. Thiazides, sulphonamides, tetracyclines and dithranol may result in phototoxic reactions. Pseudoporphyria This shows the same pattern of blistering as seen with porphyria, but urinary porphyrin studies give negative results. Nalidixic acid, tetracycline, frusemide and naproxen are the most frequently reported causes. Pemphigus This also may be precipitated by drugs and, in some cases, settle on discontinuing the medication. The most frequently reported drug associated with this is penicillamine, but other drugs including rifampicin and captopril may also induce this reaction. MODERN MEDICINE OF SOUTH AFRICA 10
B. Autoimmune blistering diseases
Go Back to the Top To Order, Visit the Purchasing Page for Details formation immediately above the basal layer. The dermal papillae, which are covered by basal cells in the single layer that is left in
More informationPROFESSIONAL INFORMATION
SCHEDULING STATUS: S1 PROPRIETARY NAME AND DOSAGE FORM: Aleve Tablets COMPOSITION: Each tablet contains naproxen sodium 220 mg (equivalent to 200 mg naproxen) CATEGORY AND CLASS: A / 2.7 Antipyretic or
More informationClassification: 1. Infective: 2. Traumatic: 3. Idiopathic: Recurrent Aphthous Stomatitis (RAS) 4. Associated with systemic disease:
Classification: 1. Infective: 2. Traumatic: 3. Idiopathic: Recurrent Aphthous Stomatitis (RAS) 4. Associated with systemic disease: Hematological GIT Behcet s HIV 5. Associated with dermatological diseases:
More informationAROMASIN 25mg (Tablets)
APPROVED PACKAGE INSERT AROMASIN SCHEDULING STATUS: S4 PROPRIETARY NAME AND DOSAGE FORM: AROMASIN 25mg (Tablets) COMPOSITION: Each sugar-coated tablet contains 25 mg exemestane. Preservative: methyl p-hydroxybenzoate
More informationEmergency Dermatology Dr Melissa Barkham
Emergency Dermatology Dr Melissa Barkham Spotlight Seminar 30 th September 2010 Why is this important? Urgent recognition and treatment of dermatologic emergencies can be life saving and prevent long term
More informationCLINCOPATHOLOGICAL CASE
CLINCOPATHOLOGICAL CASE Generalized vesiculo-bullous and pustular eruption in an adult man Hassab El-Naby H, MD, El-Khalawany M, MD Department of Dermatology, Al-Azhar University, Cairo, Egypt CLINICAL
More informationBackground information of DIF
Napa Dermatopathology Meeting 2018: Immunobullous Disease Whitney A. High, MD, JD, MEng whitney.high@ucdenver.edu Professor of Dermatology & Pathology Vice-Chairman, Dermatology Director of Dermatopathology
More informationDERMATOLOGICAL EMERGENCIES. DR. Ian Hoyle MBBS DIP IMC RCS (Ed), DA (UK),FRACGP,FACRRM,DIP DERM(Wales) TASMANIAN SKIN AND BODY CENTRE
DERMATOLOGICAL EMERGENCIES DR. Ian Hoyle MBBS DIP IMC RCS (Ed), DA (UK),FRACGP,FACRRM,DIP DERM(Wales) TASMANIAN SKIN AND BODY CENTRE Dermatological Emergencies INFECTIONS ERYTHRODERMA DRUG ERUPTIONS STEVENS-JOHNSON
More informationPaul K. Shitabata, M.D. Dermatopathology Institute
Paul K. Shitabata, M.D. Dermatopathology Institute Technical Considerations Storage of slides at room temperature
More informationHEMORRHAGIC BULLOUS HENOCH- SCHONLEIN PURPURA: A CASE REPORT
HEMORRHAGIC BULLOUS HENOCH- SCHONLEIN PURPURA: A CASE REPORT Nirmala Ponnuthurai, Sabeera Begum, Lee Bang Rom Paediatric Dermatology Unit, Institute of Paediatric, Hospital Kuala Lumpur, Malaysia Abstract
More informationDr Saleem Taibjee. Consultant Dermatologist & Dermatopathologist
Dr Saleem Taibjee saleem.taibjee@dchft.nhs.uk Consultant Dermatologist & Dermatopathologist Case S14-10797 and S15-4023 F50. Previous blistering, now marked milia on dorsum of hands. 4mm punch biopsy The
More informationBlistering skin conditions
THEME weird skin stuff Belinda Welsh MBBS, MMed, FACD, is consultant dermatologist, St Vincent's Hospital, Melbourne and Sunbury Dermatology and Skin Cancer Clinic, Sunbury, Victoria. drbwelsh@bigpond.net.au
More informationTHERE IS A GROUP OF PAtients. Defining Urticarial Dermatitis. A Subset of Dermal Hypersensitivity Reaction Pattern
STUDY Defining Urticarial Dermatitis A Subset of Dermal Hypersensitivity Reaction Pattern Steven Kossard, FACD; Ian Hamann, FACD; Barbara Wilkinson, BSc Background: Urticarial dermatitis may represent
More informationA. Erythema multiforme and related diseases
Go Back to the Top To Order, Visit the Purchasing Page for Details Chapter Erythema, Erythroderma (Exfoliative Dermatitis) Erythema is caused by telangiectasia or hyperemia in the papillary and reticular
More informationEgyptian Dermatology Online Journal Vol. 8 No 2: 6, December Yasmeen J Bhat*, Iffat Hasan*, Atiya Yaseen*, Hina Altaf*, Shylla Mir**
Pemphigoid gestationis in a multigravida Yasmeen J Bhat*, Iffat Hasan*, Atiya Yaseen*, Hina Altaf*, Shylla Mir** * Department of Dermatology, STD & Leprosy; Government Medical College, Srinagar ** Department
More informationالسكري للداء مرافقة فقاعات diabeticorum= Bullosis
1 / 6 Bullosis diabeticorum Bullous disease of diabetes (bullosis diabeticorum) is a distinct, spontaneous, noninflammatory, blistering condition of acral skin unique to patients with diabetes mellitus.
More informationA case of bullous pemphigoid following pemphigus foliaceus
#2228 A case of bullous pemphigoid following pemphigus foliaceus Priyanka Vedak MD 1, Danielle Levine MD 1,3, Lyn Duncan MD 2,3, Hensin Tsao 1,3, Daniela Kroshinsky MD MPH 1,3 1. Department of Dermatology,
More informationRosuvastatin 5 mg, 10 mg and 20 mg Tablet
Rosuvastatin 5 mg, 10 mg and 20 mg Tablet Description is a preparation of Rosuvastatin. Rosuvastatin is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to
More information* Adults. NSAID associated peptic ulceration: - Acute treatment: 150 mg twice daily for 8 to 12 weeks, or 300mg nocte.
Trade Name Aciloc 75 mg & 300 mg Film-coated tablets Generic Name Ranitidine Composition Each Aciloc 300 mg film-coated tablet contains: - Active ingredient: Ranitidine hydrochloride 336 mg equivalent
More informationTILAZEM. Diltiazem hydrochloride 240 mg
Tilazem Capsules Page 1 of 9 TILAZEM Diltiazem hydrochloride SCHEDULING STATUS: S3 PROPRIETARY NAME (AND DOSAGE FORM): TILAZEM 180 CR (controlled-release capsule) TILAZEM 240 CR (controlled-release capsule)
More informationPharmacologyonline 1: 1-6 (2010) Case Report Ravishankar and Hiremath CIPROFLOXACIN INDUCED BULLOUS PEMPHIGOID: A CASE REPORT
CIPROFLOXACIN INDUCED BULLOUS PEMPHIGOID: A CASE REPORT Ravishankar AC 1*, Hiremath SV 1 1 Dept of Pharmacology and Pharmacotherapeutics, JN Medical College, Belgaum, India. Summary Bullous pemphigoid
More informationAn Approach to Common and not so Common Rashes in the Office FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc
An Approach to Common and not so Common Rashes in the Office FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc 1 Common Rashes Tinea Corporis: Annular- this is not the only criteria Advancing erythematous
More informationEMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated
EMILOK Global (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated granules. Properties: Emilok (omeprazole) belongs to the group of proton pump inhibitors, inhibits both
More informationSCHEDULING STATUS: S0 For pack sizes of 24 tablets or less. For pack sizes of more than 24 tablets
SCHEDULING STATUS: S0 For pack sizes of 24 tablets or less S1 For pack sizes of more than 24 tablets PROPRIETARY NAME: AND DOSAGE FORM PANADO MELTABS (Tablets) COMPOSITION: Each tablet contains 500 mg
More informationAutoimmune Diseases with Oral Manifestations
Autoimmune Diseases with Oral Manifestations Martin S. Greenberg DDS, FDS RCSEd Professor Emeritus Department of Oral Medicine University of Pennsylvania Disclosure Statement I have no actual or potential
More informationMetformin Hydrochloride
Metformin Hydrochloride 500 mg, 850 mg, 500 mg LA and 750 mg LA Tablet Description Informet is a preparation of metformin hydrochloride that belongs to a biguanide class of oral antidiabetic drugs. Metformin
More information50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate).
DUPISOR Composition Gel 50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate). Action Calcipotriol is a non-steroidal antipsoriatic agent, derived from vitamin D. Calcipotriol
More informationCetirizine Proposed Core Safety Profile
Cetirizine Proposed Core Safety Profile Posology and method of administration Elderly subjects: data do not suggest that the dose needs to be reduced in elderly subjects provided that the renal function
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Lopid 450 mg film-coated tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 450 mg gemfibrozil. For
More information0BCore Safety Profile. Pharmaceutical form(s)/strength: Cream 1% DK/H/PSUR/0009/005 Date of FAR:
0BCore Safety Profile Active substance: Pimecrolimus Pharmaceutical form(s)/strength: Cream 1% P-RMS: DK/H/PSUR/0009/005 Date of FAR: 06.06.2013 4.3 Contraindications Hypersensitivity to pimecrolimus,
More informationCOPYRIGHTED MATERIAL. Introduction CHAPTER 1. Introduction
CHAPTER 1 Introduction OVERVIEW The clinical features of skin lesions are related to the underlying pathological processes. Broadly skin conditions fall into three clinical groups: (a) those with a well-defined
More informationCutaneous Drug Reactions
Cutaneous Drug Reactions Andrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada Copyright 2017 by Sea Courses
More informationChildren Enteric coated tablet : 1-3 mg/kg per day in divided doses.
Ultrafen Tablet/SR Tablet/Suppository/Gel Description Ultrafen is a preparation of Diclofenac is a non-steroidal antiinflammatory agent with marked analgesic, anti-inflammatory and antipyretic properties.
More informationFigure 25.1 Figure 25.2
CASE 25 Patient: A 75-year-old Thai man from Lamphun Chief Complaint: 6-month-history of itchy vesicles at both thighs and elbows, upper back and sacral area Present Illness: The patient presented with
More informationAcquired and Inherited Bullous Diseases
Acquired and Inherited Bullous Diseases Erin Wei MD Brigham and Women s Hospital, Department of Dermatology Instructor, Harvard Medical School Director, Bullous Disease Clinic No disclosures Conflict of
More informationAction Naproxen sodium, the active principle of Naproxan, has been developed as an analgesic because it is more rapidly absorbed than Naproxen.
NAPROXAN Composition Each tablet contains Naproxen sodium 275 mg. Tablets Action Naproxen sodium, the active principle of Naproxan, has been developed as an analgesic because it is more rapidly absorbed
More informationMeningococcal polysaccharide vaccine Group A, Group C, Group Y and Group W-135
MENOMUNE ACYW-135 Meningococcal polysaccharide vaccine Group A, Group C, Group Y and Group W-135 Description The vaccine is a freeze-dried preparation of the group specific antigens from Neisseria meningitidis,
More informationImmodium / loprarmide
Immodium / loprarmide IMODIUM (loperamide hydrochloride) is indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease.
More informationVulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough
Vulval dermatoses Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough Pigmentation Vulvodynia Ulcers Genetic Pruritus VULVAL
More informationVARICELLA. Infectious and Tropical Pediatric Division, Department of Child Health, Medical Faculty, University of Sumatera Utara
VARICELLA (Chicken pox) Infectious and Tropical Pediatric Division, Department of Child Health, Medical Faculty, University of Sumatera Utara Definition : Varicella is a common contagious disease caused
More informationEmergency Dermatology. Emergency Dermatology
Emergency Dermatology These are rapidly progressive skin conditions and some are potentially lifethreatening. Early recognition is important to implement prompt supportive care and therapy. Some are drug
More informationWhat s causing this rash?
Case 1 What s causing this rash? A 38-year-old woman presents with a pruritic, tender rash on the trunk and extremities that has not changed over the past few days (Figure 1). She has taken fluvastatin
More informationVesiculobullous Diseases
Vesiculobullous Diseases Larkin Community Hospital/NSU-COM Presenters: Yuri Kim, DO, Sam Ecker, DO, Jennifer David, DO, MBA Program Director: Stanley Skopit, DO, MSE, FAOCD, FAAD We have no relevant disclosures
More informationPharmaceutical form(s)/strength: Capsules, 200mg, 400mg, Oral suspensions, 90mg/5ml, 180mg/5ml, 36 mg/ml SI/H/PSUR/0002/002 Date of FAR:
0BCore Safety Profile Active substance: Ceftibuten Pharmaceutical form(s)/strength: Capsules, 200mg, 400mg, Oral suspensions, 90mg/5ml, 180mg/5ml, 36 mg/ml P-RMS: SI/H/PSUR/0002/002 Date of FAR: 14.02.2013
More informationThe usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.
Name Gasec - 2 Gastrocaps Composition Gasec-20 Gastrocaps Each Gastrocaps contains: Omeprazole 20 mg (in the form of enteric-coated pellets) Properties, effects Proton Pump Inhibitor Omeprazole belongs
More informationatorvastatin 10mg, amlodipine 5mg and dilitazem 60mg. He had unexplained iron deficiency anaemia (hemoglobin-8.4gm/dl, ferritin- 4.73ng/ml, total iron
Pemphigus herpetiformis : A rare clinical variant of pemphigus Shrestha P 1, Tajhya RB 2, Pokharel A 3 1,2 Consultant Dermatologist, Department of Dermatology, Vayodha Hospital Pvt. Ltd, Balkhu, Kathmandu,
More informationDERMATOLOGY SKIN DISEASE: APPROACH TO DIAGNOSIS
DERMATOLOGY SKIN DISEASE: APPROACH TO DIAGNOSIS History Clinical Examination List and Prioritise Differentials Diagnostic Testing/Trials (eg Treatment Trial) Correlate All Findings History Signalment age,
More informationProceedings of the Southern European Veterinary Conference - SEVC -
Close this window to return to IVIS www.ivis.org Proceedings of the Southern European Veterinary Conference - SEVC - Sep. 30-Oct. 3, 2010, Barcelona, Spain Next SEVC Conference: Sep. 30-Oct. 2, 2011 -
More informationTERRY WHITE CHEMISTS GEMFIBROZIL TABLETS
TERRY WHITE CHEMISTS GEMFIBROZIL TABLETS NAME OF THE MEDICINE Gemfibrozil. Chemical name: 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid. Structural Formula Me Me Me O COOH Me Molecular Formula: C
More informationPrescribing Information
Prescribing Information Pr DERMOVATE Cream (clobetasol propionate cream, USP) Pr DERMOVATE Ointment (clobetasol propionate ointment, USP) Topical corticosteroid TaroPharma Preparation Date: A Division
More informationRABEPRAZOL 10mg and 20mg Gastro-resistant Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet
More informationINDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.
Page 1 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME (and dosage form) ACULAR 0,4% COMPOSITION ACULAR 0,4% ophthalmic solution contains: Ketorolac tromethamine: 4 mg/ml Preservative: Benzalkonium chloride
More informationAntihyperlipidemic Drugs
Antihyperlipidemic Drugs Lipid disorders: Disorders of lipid metabolism are manifest by elevation of the plasma concentrations of the various lipid and lipoprotein fractions (total and LDL cholesterol,
More informationMabThera. SC. The wait is over. MabThera delivered in just 5 minutes. SC= subcutaneous injection
MabThera SC. The wait is over. MabThera delivered in just 5 minutes Abbreviated Prescribing Information MabThera 1400 mg solution for subcutaneous (SC) injection (Rituximab) Indications: Indicated in adults
More informationCutaneous Adverse Drug Reactions in Domestic Animals. Katherine Doerr, DVM, Dip. ACVD. Veterinary Dermatology Center
Cutaneous Adverse Drug Reactions in Domestic Animals Katherine Doerr, DVM, Dip. ACVD Veterinary Dermatology Center Maitland, Rockledge, Waterford Lakes, FL Not highly studied in veterinary medicine Unknown
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Comfora 595 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains: glucosamine sulphate
More informationClinical diagnosis? AIP (Acute Intermittent Porphyria)
Case 1 18 yo woman came to ER with a 5-day history of severe abdominal pain Localized, intermittent, sharp, epigastric and periumbilical pain associated with mild nausea but no vomiting for the past 6
More informationEtoricoxib STADA 30 mg, 60 mg, 90 mg and 120 mg film-coated tablets , Version V1.2 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN
Etoricoxib STADA 30 mg, 60 mg, 90 mg and 120 mg film-coated tablets 23.5.2016, Version V1.2 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN VI.2 Elements for a Public Summary Etoricoxib STADA 30 mg film-coated
More informationEpidermolysis Bullosa Acquisita
Introduction Epidermolysis Bullosa Acquisita Pages with reference to book, From 192 To 194 Nasser Rashid Dar ( Departments of Dermatology, Combined Military Hospital, Peshawar. ) Ahsan Hameed, Ashfaq Ahmad
More informationIf a drug trigger is suspected, stop the offending drug as this may reduce the risk of relapse.
There is so much we don't know in medicine that could make a difference, and often we focus on the big things, and the little things get forgotten. To highlight some smaller but important issues, we've
More informationVANLID Capsules (Vancomycin hydrochloride)
Published on: 22 Sep 2014 VANLID Capsules (Vancomycin hydrochloride) Composition VANLID Capsules Each capsule contains: Vancomycin Hydrochloride IP equivalent to Vancomycin.. 250 mg Approved colours used
More informationDepartment of Dermatology, Christian Medical College and Hospital, Ludhiana, Punjab, India.
Bullous pemphigoid mimicking granulomatous inflammation Abhilasha Williams, Emy Abi Thomas. Department of Dermatology, Christian Medical College and Hospital, Ludhiana, Punjab, India. Egyptian Dermatology
More informationNicotinic Acid Nicotinic Acid
Nicotinic Acid Nicotinic Acid PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredient: Nicotinic acid BP 250 mg. Structural formula: Molecular weight: 123.1 CAS Registry no.: 59-67-6 DESCRIPTION Inactive
More informationFuture of Pediatrics: Blisters, Hives and Other Tales from the Emergency Room June 14 th, 2016
A. Yasmine Kirkorian MD Assistant Professor of Dermatology & Pediatrics Children s National Health System George Washington University School of Medicine & Health Sciences Future of Pediatrics: Blisters,
More informationOriginal Contribution
Direct Immunofluorescence Test of Skin Biopsy Samples Results of 204 Cases Kabir AN, 1 Das RK, 2 Kamal M 3 Direct immunofluorescence (DIF) test of skin and renal biopsy specimens is being done on regular
More informationRashes Not To Be Missed In Children
May 2016 Rashes Not To Be Missed In Children Dr Chan Yuin Chew Dermatologist Dermatology Associates Gleneagles Medical Centre Scope of presentation Focus on rashes May lead to significant morbidity if
More informationDermatitis Herpetiformis (DH) in Association with H. pylori Infection: Description of a Case Report
British Journal of Medicine & Medical Research 1(3): 163-169, 2011 SCIENCEDOMAIN international www.sciencedomain.org Dermatitis Herpetiformis (DH) in Association with H. pylori Infection: Description of
More informationTo Correlate Clinical Diagnosis with Histopathology and DIF Pattern of Autoimmune Based Vesiculobullous Disorders In A Tertiary Teaching Hospital
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 7 Ver. 2 (July. 2018), PP 01-06 www.iosrjournals.org To Correlate Clinical Diagnosis with Histopathology
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Each tablet contains 100 mg of trimethoprim. For the full list of excipients, see section 6.1.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Trimethoprim 100 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 100 mg of trimethoprim. For the full list
More informationAPPROVED PACKAGE INSERT
Page 1 of 6 APPROVED PACKAGE INSERT SCHEDULING STATUS: S4 PROPRIETARY NAME AND DOSAGE FORM: CYKLOKAPRON T 500 (Tablets) CYKLOKAPRON IV 500 (Injection) COMPOSITION: Each tablet contains 500 mg tranexamic
More informationPfizer Laboratories (Pty) Ltd P&U Etoposide CSV Range Approved PI: 12 Sep 2005 Page 1 of 5
Approved PI: 12 Sep 2005 Page 1 of 5 SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): P&U ETOPOSIDE CSV 100 mg/5 ml INJECTION (INJECTION CONCENTRATE FOR INTRAVENOUS INFUSION) P&U ETOPOSIDE CSV
More informationPACKAGE INSERT. 10mg: Each enteric-coated delayed release tablet contains 10 mg of rabeprazole sodium, equivalent
PACKAGE INSERT SCHEDULING STATUS Schedule 4 PROPRIETARY NAME (and dosage form) PARIET 10 mg tablets PARIET 20 mg tablets COMPOSITION 10mg: Each enteric-coated delayed release tablet contains 10 mg of rabeprazole
More informationClinicopathological correlation of blistering diseases of skin
Bangladesh Med Res Counc Bull 2008; 34: 48-53 Copyright 2008 by Bangladesh Medical Research Council Clinicopathological correlation of blistering diseases of skin A.K.M. Nurul Kabir 1, Mohammed Kamal 1
More informationGROUP 15 TOPICAL PREPARATIONS
- 105 - GROUP 15 15.1 DERMATOLOGICAL PREPARATIONS 15.1.1 TOPICAL ANTIFUNGALS CLOTRIMAZOLE Indication: Treatment of susceptible fungal infections, dermatophytoses, superficial mycoses, and cutaneous candidiasis
More informationAPPROVED PACKAGE INSERT
APPROVED PACKAGE INSERT SCHEDULING STATUS:S3 PROPRIETARY NAMES (AND DOSAGE FORMS): PONSTAN (CAPSULES) PONSTAN FORTE (TABLET) PONSTAN (SUSPENSION) PONSTAN (PAEDIATRIC SUPPOSITORIES) COMPOSITION: PONSTAN
More informationINDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery.
Page 1 of 5 SCHEDULING STATUS Schedule 3 PROPRIETARY NAME (AND DOSAGE FORM) ACULAR 0,5 % COMPOSITION ACULAR 0,5 % contains: Preservatives: Benzalkonium chloride 0,01 % m/v Disodium edetate 0,1 % m/v PHARMACOLOGICAL
More informationDialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride
PACKAGE LEAFLET: INFORMATION FOR THE USER Dialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may
More information2018 Oregon Dental Conference Course Handout Denis Lynch, DDS, PhD
2018 Oregon Dental Conference Course Handout Denis Lynch, DDS, PhD Course 9148: Diagnosis and Treatment of Recurrent Oral Ulcers Friday, April 6 9 am - 12 pm Diagnosis and Treatment of Recurrent Oral Ulcers
More informationANTIHYPERLIPIDEMIA. Darmawan,dr.,M.Kes,Sp.PD
ANTIHYPERLIPIDEMIA Darmawan,dr.,M.Kes,Sp.PD Plasma lipids consist mostly of lipoproteins Spherical complexes of lipids and specific proteins (apolipoproteins). The clinically important lipoproteins, listed
More informationCHOLESTAGEL 625 mg Genzyme
CHOLESTAGEL 625 mg Genzyme 1. NAME OF THE MEDICINAL PRODUCT Cholestagel 625 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 625 mg colesevelam hydrochloride (hereafter
More informationAUSTRALIAN PRODUCT INFORMATION APOC-5FU CREAM (FLUOROURACIL)
AUSTRALIAN PRODUCT INFORMATION APOC-5FU CREAM (FLUOROURACIL) 1 NAME OF THE MEDICINE Fluorouracil 2 AND 3 QUALITATIVE AND QUANTITATIVE COMPOSITION AND PHARMACEUTICAL FORM APOC-5FU cream is intended for
More informationPemphigus in younger age group in Bangladeshi population
ORIGINAL ARTICLE in younger age group in Bangladeshi population Abdul Wahab 1, MD, Lubna Khondker 1, MD, Jamal Uddin 1, MD, Ishrat Bhuiyan 2, MD Shirajul Islam Khan 3, MD, Zafrul Islam 1, MD, Rahmat Ali
More informationA cross-sectional study of clinical, histopathological and direct immmunofluorescence diagnosis in autoimmune bullous diseases
Original Article A cross-sectional study of clinical, histopathological and direct immmunofluorescence diagnosis in autoimmune bullous diseases Anchal Jindal, MD 1 Rushikesh Shah, MBBS 2 Neela Patel, MD
More informationCASE REPORT ATYPICAL BULLOUS PYODERMA GANGRENOSUM WITH EARLY LESIONS MIMICKING CHICKEN POX
ATYPICAL BULLOUS PYODERMA GANGRENOSUM WITH EARLY LESIONS MIMICKING CHICKEN POX Ramesh M 1, Kavya Raju Nayak 2, M.G. Gopal 3, Sharath Kumar B.C 4, Nandini A.S 5 HOW TO CITE THIS ARTICLE: Ramesh M, Kavya
More informationPediatric Dermatology
Pediatric Dermatology --------- Emergencies & Urgencies Nicholas V. Nguyen, M.D. Director, Pediatric Dermatology Disclosures In the past 12 months, I have had the following financial relationships with
More informationof LDL and HDL cholesterol.
Ezetimibe Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain all the available information. It does not take the place of talking
More informationPackage leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride
Package leaflet: Information for the patient / / 30 mg/5 ml syrup Ambroxol hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationQuestions. Answers. Share your photos and diagnoses with us!
Illustrated quizzes on problems seen in everyday practice Case 1 A 56-year-old woman presented with a two-week history of pruritic urticarial plaques and tense bullae on both erythematous and normal skin.
More informationM0BCore Safety Profile
M0BCore Safety Profile Active substance: Aztreonam Pharmaceutical form(s)/strength: 500 mg, 1 g and 2 g powder for solution for injection and infusion NB! 75mg aztreonam for nebulisation to treat infections
More informationPAEDIATRIC ACUTE CARE GUIDELINE. Impetigo. This document should be read in conjunction with this DISCLAIMER
Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Impetigo Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should be read in conjunction
More informationIroko Pharmaceuticals Announces Acceptance for Filing of ZORVOLEX snda for the Treatment of Osteoarthritis Pain in Adults
Iroko Pharmaceuticals Announces Acceptance for Filing of ZORVOLEX snda for the Treatment of Osteoarthritis Pain in Adults First Lower Dose NSAID Using SoluMatrix Fine Particle Technology to be Reviewed
More informationPrescribing Information. Taro-Clobetasol. Taro-Clobetasol
Prescribing Information Pr Taro-Clobetasol Clobetasol Propionate Cream USP, 0.05% w/w Pr Taro-Clobetasol Clobetasol Propionate Ointment USP, 0.05% w/w Therapeutic Classification Topical corticosteroid
More information0BCore Safety Profile. Pharmaceutical form(s)/strength: Losec MUPS tablets 10, 20 mg (OTC) NL/H/PSUR/0058/001 Date of FAR:
0BCore Safety Profile Active substance: Omeprazole Pharmaceutical form(s)/strength: Losec MUPS tablets 10, 20 mg (OTC) P-RMS: NL/H/PSUR/0058/001 Date of FAR: 13.06.2013 4.2 Posology and method of administration
More informationSome skin conditions
Some skin conditions Some skin conditions Acute Inflammatory Dermatoses Chronic Inflammatory Dermatoses Blistering (Bullous) Diseases Panniculitis Disorders of Epidermal Appendages -Urticaria -Acute eczematous
More informationAusfam PRODUCT INFORMATION NAME OF THE MEDICINE DESCRIPTION PHARMACOLOGY
Ausfam PRODUCT INFORMATION NAME OF THE MEDICINE Famotidine. The chemical name for famotidine is N 2 -(aminosulphonyl)-3-[[[2-[(diamino methylene)amino]thiazol-4yl]methyl]thio]propanamidine. Its structural
More informationCUTANEOUS DRUG REACTIONS OR I WOULDN T HAVE SEEN IT, IF I HADN T BELIEVED IT Edmund J. Rosser Jr., DVM, DACVD
CUTANEOUS DRUG REACTIONS OR I WOULDN T HAVE SEEN IT, IF I HADN T BELIEVED IT Edmund J. Rosser Jr., DVM, DACVD DERMATOLOGY Pathogenesis Immunologic: can involve Type I, II, III, IV hypersensitivity reactions.
More informationImportant Safety Information
THALOMID (thalidomide) in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma (MM) THALOMID is indicated for the acute treatment of the cutaneous
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Colecalciferol Meda 800 IU tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains colecalciferol (vitamin D 3 ) 800 IU
More informationPIL. ParaCet Flu 500 mg+250 mg/sachet Powder for oral solution paracetamol + ascorbic acid
PIL ParaCet Flu 500 mg+250 mg/sachet Powder for oral solution paracetamol + ascorbic acid Please, carefully read this PIL before you start using the medicine. This medicine is available without prescription,
More informationEULEXIN PRODUCT INFORMATION NAME OF MEDICINE EULEXIN DESCRIPTION
EULEXIN PRODUCT INFORMATION NAME OF MEDICINE EULEXIN DESCRIPTION Each EULEXIN tablet contains 250 mg of flutamide, a non-steroidal, orally active antiandrogen. Each tablet also contains lactose anhydrous,
More information